Derazantinib
Drug timelines are a Plus or Pro feature.
6 regulatory and trial events tracked for Derazantinib, covering 2021-10-28 to 2025-12-05. Get the full timeline:
Most recent: Clinical Trial Update: Treatment of Atezolizumab and Derazantinib in Patients With Advanced iCCA With FGFR2 Fusions/Rearrangements [Phase 2]